The application of anti-FLT1 antibody-conjugated liposomes in glioma may provide a more targeted treatment option. By targeting the FLT1 protein, this therapeutic approach can enhance the accumulation of drugs at the tumor site, thereby improving efficacy. Future clinical trials will help verify its safety and effectiveness, bringing new hope to glioma patients.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
DrMAB-1152 | Human Anti-FLT1 Recombinant Antibody (clone 867.2A3); scFv Fragment | ELISA, WB, IHC, IP | Human scFv |
DrMAB-1158 | Human Anti-FLT1 Recombinant Antibody (clone 867.2D2); scFv Fragment, HRP | ELISA, WB, IHC, IP | Human scFv |
HPAB-1699-FY-F(E) | Mouse Anti-FLT1 Recombinant Antibody (clone CA0071-Z2ZM-01941); scFv Fragment | ELISA | Mouse scFv |
HPAB-1700-FY-F(E) | Mouse Anti-FLT1 Recombinant Antibody (clone CA0071-Z2ZA-01171); scFv Fragment | ELISA | Mouse scFv |
HPAB-1701-FY-F(E) | Mouse Anti-FLT1 Recombinant Antibody (clone CA0071-Z2ZB-01171); scFv Fragment | ELISA | Mouse scFv |
There are currently no Customer reviews or questions for VS-1024-FY97. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.